Non-Interventional Study on the Tolerability and Efficacy of IVIG

CompletedOBSERVATIONAL
Enrollment

344

Participants

Timeline

Start Date

August 1, 2011

Primary Completion Date

June 5, 2020

Study Completion Date

June 5, 2020

Conditions
Primary and Secondary Immunodeficiency and Other Conditions Requiring Regular Administration of Octagam 5% or 10% IVIG
Interventions
BIOLOGICAL

Octagam IVIG 5% or 10%

Octagam IVIG 5% or 10%

BIOLOGICAL

Panzyga

Panzyga

Trial Locations (38)

1090

Octapharma Research Site, Vienna

5020

Octapharma Research Site, Salzburg

13285

Octapharma Research Site, Marseille

13385

Octapharma Research Location, Marseille

Octapharma Research Site, Marseille

13825

Octapharma Research Center, Marseille

14033

Octapharma Research Location, Caen

Octapharma Research Site, Caen

17019

Octapharma Research Site, La Rochelle

18020

Octapharma Research Site, Bourges

28040

Octapharma Research Site, Madrid

28041

Octapharma Research Location, Madrid

Octapharma Research Site, Madrid

28046

Octapharma Research Site, Madrid

31300

Octapharma Research Site, Toulouse

33064

Octapharma Research Site, Pessac

34525

Octapharma Research Site, Béziers

35033

Octapharma Research Site, Rennes

44093

Octapharma Research Site, Nantes

58033

Octapharma Research Site, Nevers

69310

Octapharma Research Site, Pierre-Bénite

82013

Octapharma Research Site, Montauban

95107

Octapharma Research Site, Argenteuil

17 4810

Octapharma Research Site, Gmunden

22 8036

Octapharma Research Site, Graz

35 9020

Octapharma Research Site, Klagenfurt

56 5110

Octapharma Research Site, Oberndorf

V6Z 1Y6

St. Paul's Hospital, Vancouver

R3A 1R9

Health Sciences Centre, Winnipeg

L8N3Z5

Hamilton Health Sciences, Hamilton

M5B 1W8

St. Michael's Hospital, Toronto

M5G 1X8

Hospital for Sick Children, Toronto

08035

Octapharma Research Site, Barcelona

LS97TF

Octapharma Research Site, Leeds

E1 1BB

Octapharma Research Site, London

NW33QG

Octapharma Research Site, London

PL68DH

Octapharma Research Site, Plymouth

ST16 3SA

Octapharma Research Site, Stafford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Octapharma

INDUSTRY